Process for preparation of temozolomide
The invention relates to a method for industrially preparing temozolomide on a large scale, and the key intermediate 5-amino-N1-imidazole-1, 4-dicarboxamide (carbamoyl-AICA) is prepared by adopting N-methyl carbamoyl imidazole (NMCI) type I. In addition, the present invention relates to a process fo...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to a method for industrially preparing temozolomide on a large scale, and the key intermediate 5-amino-N1-imidazole-1, 4-dicarboxamide (carbamoyl-AICA) is prepared by adopting N-methyl carbamoyl imidazole (NMCI) type I. In addition, the present invention relates to a process for the preparation of NMCI type I. The NMCI type I and temozolomide are purified by crystallization without the use of a chromatographic column or continuous extraction.
本发明涉及以工业大规模制备替莫唑胺的方法,其中采用N-甲基氨基甲酰基咪唑(NMCI)I型来制备关键中间体5-氨基-N1-咪唑-1,4-二甲酰胺(氨基甲酰基-AICA)。此外,本发明涉及制备I型NMCI的方法。NMCI I型与替莫唑胺通过结晶来纯化,而无需使用色谱柱或连续提取。 |
---|